Erratum to "Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study". . Cancer 2025;131:e35803.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Erratum to "Incorporation of alemtuzumab into frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study". Cancer 2025;131:e35803.
PMID: 40045671